Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension

Hypertension is particularly prevalent in patients aged ⩾65 years, those with a body mass index ⩾30 kg m(−2), Blacks and those with type II diabetes. Here we report a prespecified secondary analysis of the efficacy of amlodipine (10 mg day(−1)), olmesartan medoxomil (40 mg day(−1)), a combination of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chrysant, S G, Lee, J, Melino, M, Karki, S, Heyrman, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963900/
https://www.ncbi.nlm.nih.gov/pubmed/20164847
http://dx.doi.org/10.1038/jhh.2010.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963900/
https://www.ncbi.nlm.nih.gov/pubmed/20164847
http://dx.doi.org/10.1038/jhh.2010.5

Ejemplares similares